Parity, hormone replacement therapy for postmenopausal women and the female sex have all been reported as protection factors against the progression of liver disease to cirrhosis, because the female hormones (oestrogen, progesterone) might play a role in delaying the onset of hepatic fibrosis [16]-[19].
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}